Analgesic Effect of Ketamine in Patients Undergoing Hysteroscopic Endometrial Thermal Ablation Surgery

Stopped early · Not applicable

Conditions studied: Pain

In brief

Hypothesis: The intraoperative administration of ketamine will result in a 30% reduction in opiate requirement following endometrial ablation surgery and the intraoperative administration of ketamine will result in a decreased time to meet discharge criteria in the PACU following endometrial ablation surgery. The research question is "Does intraoperative administration of ketamine result in decreased postoperative opiate requirement and time to discharge from the postanesthesia recovery unit (PACU) following hysteroscopic endometrial ablation".

Key facts

Study ID

NCT01106846

Run by

Northwestern University

People needed

22

Starts

2010-03-01

Expected to finish

2013-03-01

Last updated by the study team

2015-08-07

Who can join

Age: 18 and older, up to 65. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Gender: Female
• Age: 18-65 years
• Non-pregnant, non-lactating
• Surgery: Outpatient hysteroscopic Novasure® endometrial ablation
• Language: English speaking
• Consent: Obtained

You may not qualify if…

• Patient refusal
• Under 18 or over age 65
• Non-English Speaking
• Pregnancy, Breast feeding
• Hysteroscopic procedures using Thermachoice® ablation device
• Chronic use or addiction to opiates, sedatives, non-opiate analgesics
• History of heavy alcohol usage (>4 drinks/day)
• Significant cardiovascular or pulmonary disease
• Psychiatric or emotional disorder
• Allergy to anesthetic agents utilized in the protocol
• Glaucoma
• Thyrotoxicosis

Where it is running

• Northwestern University — Chicago, Illinois, United States
• Prentice Women's Hosptial — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.